Oral Biolife Awarded NIH Grant
BETHLEHEM, PA — Oral Biolife (OBL), a biotechnology company developing a first-in-class piezoelectric regenerative platform designed to stimulate new bone formation, recently announced that it has been awarded a grant from the National Institutes of Health (NIH), through the National Institute of Dental and Craniofacial Research (NIDCR), to investigate its technology as a potential non-surgical treatment approach for peri-implantitis.
